Literature DB >> 3156875

Decreased oxygen radical generation by neutrophils from patients with measles presumably owing to activation of suppressor T lymphocytes.

Y Niwa, T Sakane, K Somiya, Y Miyachi.   

Abstract

The capacity for the generation of oxygen radicals by polymorphonuclear leukocytes (PMNs) was assessed in 29 patients with measles and in control groups. Patients with secondary bacterial infections showed a significantly decreased generation of oxygen radicals; this abnormality did not persist for more than 2 months after disease onset. Normal PMNs incubated with T lymphocytes from these measles patients generated significantly fewer oxygen radicals than those incubated with T cells from either control group. However, normal PMNs incubated with non-T lymphocytes from these measles patients produced normal oxygen radical levels. In addition, irradiation above 1,500 rads of T lymphocytes abrogated the suppressive effect of T cells on PMNs. On the other hand, these abnormal findings were not observed in patients with measles but without secondary bacterial infections. The secondary bacterial infections sometimes seen in measles patients may result from a decrease in oxygen radical generation, presumably induced by the suppressive activity of the T lymphocytes of the patients.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3156875      PMCID: PMC271655          DOI: 10.1128/jcm.21.3.318-322.1985

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  18 in total

1.  Differences in oxygen metabolism of phagocytosing monocytes and neutrophils.

Authors:  M Reiss; D Roos
Journal:  J Clin Invest       Date:  1978-02       Impact factor: 14.808

2.  Enhancement by irradiated T cells of human plasma cell production: dissection of helper and suppressor functions in vitro.

Authors:  F P Siegal; M Siegal
Journal:  J Immunol       Date:  1977-02       Impact factor: 5.422

3.  Development of suppressor T lymphocytes for Epstein-Barr virus-induced B-lymphocyte outgrowth during acute infectious mononucleosis: assessment by two quantitative systems.

Authors:  R T Schooley; B F Haynes; J Grouse; C Payling-Wright; A S Fauci; R Dolin
Journal:  Blood       Date:  1981-03       Impact factor: 22.113

4.  Activation of suppressor T cells during Epstein-Barr-virus-induced infectious mononucleosis.

Authors:  G Tosato; I Magrath; I Koski; N Dooley; M Blaese
Journal:  N Engl J Med       Date:  1979-11-22       Impact factor: 91.245

5.  Infectious mononucleosis: sequential immunologic, cytochemical, and cytokinetic studies on single lymphoid cells in peripheral blood.

Authors:  A Hirt; P Imbach; A Morell; H P Wagner
Journal:  Blood       Date:  1981-09       Impact factor: 22.113

6.  Decrease in generation of reactive oxygen species by neutrophils from patients with infectious mononucleosis: role of suppressor T lymphocytes.

Authors:  Y Niwa; T Sakane; Y Miyachi; T Kanoh; K Somiya
Journal:  Blood       Date:  1984-11       Impact factor: 22.113

7.  Immunological behaviour following rubella infection.

Authors:  Y Niwa; T Kanoh
Journal:  Clin Exp Immunol       Date:  1979-09       Impact factor: 4.330

8.  Modification of zymosan-induced release of lysosomal enzymes from human polymorphonuclear leukocytes by cytochalasin B.

Authors:  J L Skosey; E Damgaard; D Chow; L B Sorensen
Journal:  J Cell Biol       Date:  1974-09       Impact factor: 10.539

9.  Suppression of in vitro Epstein-Barr virus infection. A new role for adult human T lymphocytes.

Authors:  D A Thorley-Lawson; L Chess; J L Strominger
Journal:  J Exp Med       Date:  1977-08-01       Impact factor: 14.307

10.  Effect of cytochalasin B on response of human polymorphonuclear leukocytes to zymosan.

Authors:  J L Skosey; D Chow; E Damgaard; L B Sorensen
Journal:  J Cell Biol       Date:  1973-04       Impact factor: 10.539

View more
  1 in total

1.  The state of the world's children.

Authors:  J A Sills; D J Manning; C A Hart
Journal:  Arch Dis Child       Date:  1986-04       Impact factor: 3.791

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.